S9-CMC1 TFA
S9-CMC1 TFA is a covalent LSD1 inhibitor (IC50=2.53 μM) targeting Cys360. It increases H3K4me1/2 levels, leading to cell cycle arrest, apoptosis, and suppressed proliferation in vitro, and demonstrates significant antitumor efficacy in A549 xenograft models in vivo for cancer research.
Product Specifications
Field of Research
Cell Biology, Epigenetics & Chromatin, Immunology & Inflammation
Molecular Weight
2158.57
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS7058308 Inquire
Recombinant Methanosarcina mazei Tetrahydromethanopterin S-methyltransferase subunit F (mtrF), partial
Sign In for Pricing
View Details 
TP720989L 500 µg
Calcitonin (CALCA) (NM_001033952) Human Recombinant Protein
Sign In for Pricing
View Details 
